66. Identification and Characterization of a B Cell Aptamer That Targets Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Myelogenous Leukemia (CML)

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33671-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma

Nature
Multidisciplinary
2010English

Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Diffuse Large B-Cell Lymphoma

2020English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

A B-Cell Lymphoma Case That Is Unclassifiable, and Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma of Lacrimal Gland

International Medical Case Reports Journal
Medicine
2017English

Simultaneous Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl) at the Diagnosis Has Similar Outcome as DLBCL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma (Dlbcl): A Large Population-Based Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy